Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Total
Beginning Balance at Dec. 31, 2020	$ 8	$ 424,823	$ (317,506)		$ 107,325
Beginning Balance (in shares) at Dec. 31, 2020	81,669,151
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(65,101)		(65,101)
Stock-based compensation		4,462			4,462
Stock-based compensation - earnout		12,373			12,373
Issuance of common stock for acquisitions		1,169			1,169
Issuance of common stock for acquisitions (in shares)	90,000
Reclassification of earnout liability upon vesting		25,815			25,815
Vesting of restricted stock awards (in shares)	2,078,102
Exercise of stock warrants	$ 1	93,007			93,008
Exercise of stock warrants (in shares)	8,087,623
Exercise of stock options		355			355
Exercise of stock options (in shares)	593,106
Income tax withholdings		(16,997)			(16,997)
Income tax withholdings (in shares)	(1,062,250)
Transaction costs		(402)			(402)
Ending Balance at Mar. 31, 2021	$ 9	544,605	(382,607)		162,007
Ending Balance (in shares) at Mar. 31, 2021	91,455,732
Beginning Balance at Dec. 31, 2021	$ 10	641,406	(424,112)	$ (259)	217,045
Beginning Balance (in shares) at Dec. 31, 2021	97,961,597
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss			(5,796)		(5,796)
Other comprehensive income				(2,515)	(2,515)
Stock-based compensation		5,854			5,854
Contingent consideration for acquisitions		530			530
Vesting of restricted stock awards (in shares)	245,855
Exercise of stock options		473			473
Exercise of stock options (in shares)	185,685
Income tax withholdings		(712)			(712)
Income tax withholdings (in shares)	(95,951)
Ending Balance at Mar. 31, 2022	$ 10	$ 647,551	$ (429,908)	$ (2,774)	$ 214,879
Ending Balance (in shares) at Mar. 31, 2022	98,297,186